Removal of homodimers of bispecific antibody via mixed-mode chromatography with dual pH-salt gradients
Protein Expression and Purification · 2026-07 · 241 · 106932
DOI: 10.1016/j.pep.2026.106932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Expression and Purification, 2026-07. Verfasst von Qian Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Chia Tai-Tianqing Pharmaceutical Co.Ltd, Fanghua Pharmaceutical Research Institute, Department of Biology, Nanjing, 210046, China. Hauptthemen laut MEDLINE: Antibodies, Bispecific. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Bispecific antibodies (bsAbs) have become a research hotspot in the pharmaceutical field due to their enhanced specificity and reduced side effects. However, their complex structure, especially the unbalanced expression of heavy and light chains, readily leads to the formation of homodimers and other by-products during manufacturing, which significantly affects the efficacy and safety of bispecific antibody drugs. Therefore, developing a robust downstream purification process for effective control of homodimer-like by-products is critical. In this case study, mixed-mode chromatography combined with a pH-salt dual-gradient mode was employed to purify bispecific antibody A (bsAb-A), and the dual-gradient experimental results were further converted to a stepwise elution strategy to improve process robustness. Ultimately, polishing purification of bsAb-A by Capto MMC using 50 mM Tris-HCl (200 mM NaCl, pH 7.0) as the wash buffer and 50 mM Tris-HCl (500-600 mM NaCl, pH 7.5) as the elution buffer significantly reduced the levels of homodimers H1 and H2 as well as aggregates, while achieving a process yield above 62.9%. The results provide insights into the removal of by-products in bispecific antibody purification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanjing Chia Tai-Tianqing Pharmaceutical Co.Ltd, Fanghua Pharmaceutical Research Institute, Department of Biology, Nanjing, 210046, China.
- Nanjing Chia Tai-Tianqing Pharmaceutical Co.Ltd, Fanghua Pharmaceutical Research Institute, Department of Biology, Nanjing, 210046, China. Electronic address: XuDanNJCTTQ@163.com.
Zitieren
APA
Li, Q., Qin, G., Zhao, H., Liang, X., Wang, Z., He, Q., Li, G., & Xu, D. (2026). Removal of homodimers of bispecific antibody via mixed-mode chromatography with dual pH-salt gradients. Protein Expression and Purification, 241, 106932. https://doi.org/10.1016/j.pep.2026.106932
Vancouver
Li Q, Qin G, Zhao H, Liang X, Wang Z, He Q, et al. Removal of homodimers of bispecific antibody via mixed-mode chromatography with dual pH-salt gradients. Protein Expression and Purification. 2026;241:106932. doi:10.1016/j.pep.2026.106932
BibTeX
@article{Li2026,
author = {Li, Qian and Qin, Guohong and Zhao, Hongyang and Liang, Xiaoying and Wang, Zicheng and He, Qingquan and Li, Guozhu and Xu, Dan},
title = {Removal of homodimers of bispecific antibody via mixed-mode chromatography with dual pH-salt gradients},
journal = {Protein Expression and Purification},
year = {2026},
volume = {241},
pages = {106932},
doi = {10.1016/j.pep.2026.106932}
}
EUVIMED